Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, Mounjaro side effects begin within the first day or two after the initial injection. The earliest signs are almost always digestive — nausea, queasiness or a feeling of fullness that arrives sooner than expected at meals. They tend to be at their most noticeable in the first week at each dose level, then ease for the majority of people within days to a fortnight. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses suitability, including your risk of side effects, before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide (the active medicine in Mounjaro) works partly by slowing how quickly food leaves your stomach. That mechanism is effective for weight loss, but it also explains why your gut tends to notice the medicine quickly. If you are wondering how soon after taking Mounjaro side effects can start, most people who experience them feel something within a day of their first injection, often a mild queasiness or a sensation of being very full after eating very little.
The full side-effect picture for Mounjaro covers a wider range of symptoms, but the ones that tend to arrive earliest are nausea, burping, indigestion and, for some people, loose stools. Fatigue and a mild headache are also reported in the first few days, particularly at the start of treatment. These are consistent with what the NHS describes for tirzepatide — you can read the patient-level overview on the NHS tirzepatide medicines page.
The 2.5 mg starting dose exists specifically to reduce the intensity of these early effects. It is a tolerability step: your system gets a chance to adjust before the dose climbs. That said, some people still notice symptoms at 2.5 mg. That is normal and does not mean you will struggle at every level that follows, many find each new dose brings a brief recurrence of mild nausea that fades within a week.
Eating smaller portions, avoiding fatty or very rich meals, and staying well hydrated all help. These are practical measures, not cures, and your prescriber or the Patient Information Leaflet can give you more specific guidance than we can here.
A question our prescribers hear most weeks is whether returning nausea at a higher dose means something is wrong. In most cases it does not. The side-effect timeline tends to repeat in a mild form each time the dose steps up, then settles again. If it settled at 2.5 mg, there is a reasonable basis for expecting it to settle at 5 mg and beyond, though that is a clinical judgement, not a promise.
This rhythm is part of why the question of how long effects last is as relevant as when they start. The two timelines travel together: effects arrive early, peak briefly, then fade as your body adapts. People who push through the first week or so at each new strength often find the side-effect burden reduces significantly. Those who find it does not reduce, or who experience symptoms that go beyond the usual digestive complaints, need a conversation with their prescriber rather than a longer wait.
Dose timing matters too. Taking your injection on a consistent day each week, and eating cautiously in the hours after, can reduce the sharpness of early-dose effects. Details like injection technique and timing are covered in the Patient Information Leaflet; if you have questions between doses, our aftercare team is available seven days a week.
Most Mounjaro side effects are self-limiting and mild. A few are not. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, infrequent but potentially serious effect of GLP-1 medicines. The key symptom to watch for is severe, persistent stomach pain, particularly if it radiates toward the back or is accompanied by vomiting that does not settle. This is not typical nausea. It warrants urgent medical attention.
Other symptoms that should not be waited out include signs of a serious allergic reaction (swelling of the face, lips or throat; difficulty breathing), significant dehydration from repeated vomiting or diarrhoea, and any sudden or unusual changes in vision. If something feels wrong in a way that goes beyond predictable digestive discomfort, the right call is to contact your GP or NHS 111, not to search for reassurance online.
For context on the less common but more serious effects of Mounjaro, we have a dedicated page that goes into each in detail. You can also report any suspected side effect directly to the MHRA at yellowcard.mhra.gov.uk, Yellow Card reports help regulators monitor medicine safety in the real world, and they are open to patients as well as clinicians.
Mounjaro is not suitable for everyone, and the likelihood of experiencing side effects at a manageable level is part of what a prescriber considers before approving treatment. Certain health histories (including a personal or family history of pancreatitis, specific gastrointestinal conditions, or some medicines taken alongside) affect the risk profile in ways that a prescriber needs to know about. Our page on how soon Mounjaro side effects can appear gives a useful overview of what to expect in the early stages of treatment.
At nume, a GPhC-registered Independent Prescriber reads every consultation personally on the day it is submitted. There are no automated approvals. The consultation covers your medical background, current medicines, and weight history; side effects and how to manage them are a natural part of that conversation. For those who want a clearer picture of what to expect after Mounjaro side effects begin, we cover how symptoms typically progress and when most people notice them easing. If you are already on treatment elsewhere and are considering how different weight-loss options compare, or if you are new to this and want to understand what Mounjaro involves from the start, the right place to begin is a consultation rather than a comparison table.
Our clinical team's approach and our wider frequently asked questions cover the process in more depth. To check whether Mounjaro is clinically suitable for you, start your free consultation, our prescribers discuss suitability and side effects as part of every assessment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.